Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

November 14, 2019

Correspondence
Gut microbiome in rheumatic diseases
Free

Sergey Moiseev, Vilen Rameev, Ekaterina Karovaikina, Lidia Lysenko (Kozlovskaya)

doi: 10.1136/annrheumdis-2019-216560

November 11, 2019

Letter
Effect of belimumab treatment on antiphospholipid antibodies levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus

Katerina Chatzidionysiou, Evangelia Samoli, Petros P Sfikakis, Maria G Tektonidou

doi: 10.1136/annrheumdis-2019-216367

November 09, 2019

Paediatric rheumatology
Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis

Pui Y Lee, Grant S Schulert, Scott W Canna, Yuelong Huang, Jacob Sundel, Ying Li, Kacie J Hoyt, Rachel B Blaustein, Alexandra Wactor, Thuy Do, Olha Halyabar, Margaret H Chang, Fatma Dedeoglu, Siobhan M Case, Esra Meidan, Mindy S Lo, Robert P Sundel, Edward T Richardson, Jane W Newburger, Michael S Hershfield, Mary Beth Son, Lauren A Henderson, Peter A Nigrovic

doi: 10.1136/annrheumdis-2019-216030

November 08, 2019

Systemic lupus erythematosus
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment

Christina Adamichou, Dionysis Nikolopoulos, Irini Genitsaridi, Alessandra Bortoluzzi, Antonis Fanouriakis, Emmanouil Papastefanakis, Eleni Kalogiannaki, Irini Gergianaki, Prodromos Sidiropoulos, Dimitrios T Boumpas, George K Bertsias

doi: 10.1136/annrheumdis-2019-216155
Systemic Lupus erythematosus
NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus

Petrus Linge, Sabine Arve, Lina M Olsson, Dag Leonard, Christopher Sjöwall, Martina Frodlund, Iva Gunnarsson, Elisabet Svenungsson, Helena Tydén, Andreas Jönsen, Robin Kahn, Åsa Johansson, Lars Rönnblom, Rikard Holmdahl, Anders Bengtsson

doi: 10.1136/annrheumdis-2019-215820

November 07, 2019

Rheumatoid arthritis
Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population

Toshihiro Kishikawa, Yuichi Maeda, Takuro Nii, Daisuke Motooka, Yuki Matsumoto, Masato Matsushita, Hidetoshi Matsuoka, Maiko Yoshimura, Shoji Kawada, Satoru Teshigawara, Eri Oguro, Yasutaka Okita, Keisuke Kawamoto, Shinji Higa, Toru Hirano, Masashi Narazaki, Atsushi Ogata, Yukihiko Saeki, Shota Nakamura, Hidenori Inohara, Atsushi Kumanogoh, Kiyoshi Takeda, Yukinori Okada

doi: 10.1136/annrheumdis-2019-215743

November 06, 2019

Myositis
First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort

Masatoshi Jinnin, Akiko Ohta, Shoichiro Ishihara, Hirofumi Amano, Tatsuya Atsumi, Manabu Fujimoto, Takashi Kanda, Yasushi Kawaguchi, Atsushi Kawakami, Akio Mimori, Tsuneyo Mimori, Toshihide Mimura, Yoshinao Muro, Hajime Sano, Jun Shimizu, Tsutomu Takeuchi, Yoshiya Tanaka, Kazuhiko Yamamoto, Takayuki Sumida, Hitoshi Kohsaka The Research Team for Autoimmune Diseases, The Research Program for Intractable Disease of the Ministry of Health, Labor and Welfare

doi: 10.1136/annrheumdis-2019-215488
Letter
Increased risk of multiple myeloma in primary Sjögren’s syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies

Johannes Mofors, Albin Björk, Karin E Smedby, Marika Kvarnström, Helena Forsblad-d'Elia, Sara Magnusson-Bucher, Per Eriksson, Thomas Mandl, Eva Baecklund, Gunnel Nordmark, Marie Wahren-Herlenius

doi: 10.1136/annrheumdis-2019-216287
Inflammatory arthritis
Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition

Jian Yin, Peter Richard Sternes, Mingbang Wang, Jing Song, Mark Morrison, Ting Li, Ling Zhou, Xin Wu, Fusheng He, Jian Zhu, Matthew A Brown, Huji Xu

doi: 10.1136/annrheumdis-2019-215763

November 05, 2019

Correspondence
Temporal ultrasound for monitoring tocilizumab treatment in giant cell arteritis: seeing beyond serum markers?
Free

Gerasimos Evangelatos, George E Fragoulis, Alexios Iliopoulos

doi: 10.1136/annrheumdis-2019-216527

November 04, 2019

Spondyloarthritis
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)

Maxime Dougados, James Cheng-Chung Wei, Robert Landewé, Joachim Sieper, Xenofon Baraliakos, Filip Van den Bosch, Walter P Maksymowych, Joerg Ermann, Jessica A Walsh, Tetsuya Tomita, Atul Deodhar, Désirée van der Heijde, Xiaoqi Li, Fangyi Zhao, Clinton C Bertram, Gaia Gallo, Hilde Carlier, Lianne S Gensler On behalf of COAST-V and COAST-W Study Groups

doi: 10.1136/annrheumdis-2019-216118

October 31, 2019

Recommendation
EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies
Free

Manuel Ramos-Casals, Pilar Brito-Zerón, Stefano Bombardieri, Hendrika Bootsma, Salvatore De Vita, Thomas Dörner, Benjamin A Fisher, Jacques-Eric Gottenberg, Gabriela Hernandez-Molina, Agnes Kocher, Belchin Kostov, Aike A. Kruize, Thomas Mandl, Wan-Fai Ng, Soledad Retamozo, Raphaèle Seror, Yehuda Shoenfeld, Antoni Sisó-Almirall, Athanasios G. Tzioufas, Claudio Vitali, Simon Bowman, Xavier Mariette On behalf of the EULAR-Sjögren Syndrome Task Force Group

doi: 10.1136/annrheumdis-2019-216114
Paediatric rheumatology
Factors associated with long-term cardiac dysfunction in neonatal lupus

Amit Saxena, Peter M Izmirly, Rebecca P Bomar, Rachel Shireen Golpanian, Deborah M Friedman, Ruth Eisenberg, Mimi Y Kim, Jill P Buyon

doi: 10.1136/annrheumdis-2019-215900
Epidemiology
Comparative risk of serious infections among real-world users of biologics for psoriasis or psoriatic arthritis

Xintong Li, Kathleen M Andersen, Hsien-Yen Chang, Jeffrey R Curtis, G Caleb Alexander

doi: 10.1136/annrheumdis-2019-216102

October 30, 2019

Spondyloarthritis
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis

Uta Kiltz, Robert B M Landewé, Désirée van der Heijde, Martin Rudwaleit, Michael H Weisman, Nurullah Akkoc, Annelies Boonen, Jan Brandt, Philippe Carron, Maxime Dougados, Laure Gossec, Merryn Jongkees, Pedro M Machado, Helena Marzo-Ortega, Anna Molto, Victoria Navarro-Compán, Karin Niederman, Percival Degrava Sampaio-Barros, Gleb Slobodin, Filip E Van den Bosch, Astrid van Tubergen, Salima van Weely, Dieter Wiek, Juergen Braun

doi: 10.1136/annrheumdis-2019-216034
Crystal arthropathies
Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care

Edward Roddy, Kris Clarkson, Milica Blagojevic-Bucknall, Rajnikant Mehta, Raymond Oppong, Anthony Avery, Elaine M Hay, Carl Heneghan, Liz Hartshorne, Julie Hooper, Gemma Hughes, Sue Jowett, Martyn Lewis, Paul Little, Karen McCartney, Kamal R Mahtani, David Nunan, Miriam Santer, Sam Williams, Christian D Mallen

doi: 10.1136/annrheumdis-2019-216154

October 29, 2019

Inflammatory arthritis
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

Kevin L Winthrop, Michael E Weinblatt, Joan Bathon, Gerd R Burmester, Philip J Mease, Leslie Crofford, Vivian Bykerk, Maxime Dougados, James Todd Rosenbaum, Xavier Mariette, Joachim Sieper, Fritz Melchers, Bruce N Cronstein, Ferry C Breedveld, Joachim Kalden, Josef S Smolen, Daniel Furst

doi: 10.1136/annrheumdis-2019-216151
Rheumatoid arthritis
Shared decision making in routine clinical care of patients with rheumatoid arthritis: an assessment of audio-recorded consultations

Elke G E Mathijssen, Johanna E Vriezekolk, Calin D Popa, Bart J F van den Bemt

doi: 10.1136/annrheumdis-2019-216137
Spondyloarthritis
Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS)

Gary J Macfarlane, Ovidiu Rotariu, Gareth T Jones, Ejaz Pathan, Linda E Dean

doi: 10.1136/annrheumdis-2019-216143
Early arthritis
FGFR3 deficiency enhances CXCL12-dependent chemotaxis of macrophages via upregulating CXCR7 and aggravates joint destruction in mice

Liang Kuang, Jiangyi Wu, Nan Su, Huabing Qi, Hangang Chen, Siru Zhou, Yan Xiong, Xiaolan Du, Qiaoyan Tan, Jing Yang, Min Jin, Fengtao Luo, Junjie Ouyang, Bin Zhang, Zuqiang Wang, Wanling Jiang, Liang Chen, Shuai Chen, Ziming Wang, Peng Liu, Liangjun Yin, Fengjin Guo, Chuxia Deng, Di Chen, Chuanju Liu, Yangli Xie, Zhenhong Ni, Lin Chen

doi: 10.1136/annrheumdis-2019-215696

October 25, 2019

Letter
Molecular typing of cryoglobulins by mass spectrometry

Adrian YS Lee, Tim Chataway, Thomas P Gordon, Jing Jing Wang

doi: 10.1136/annrheumdis-2019-216091
Correspondence
Association between osteoporosis and statins therapy
Free

Shih-Wei Lai

doi: 10.1136/annrheumdis-2019-216464
Correspondence response
Adapting the MS score for detection of macrophage activation syndrome in adult-onset Still’s disease. Response to ‘Application of MS score in macrophage activation syndrome patients associated with adult onset Still’s disease’ by Wang et al
Free

Francesca Minoia, Angelo Ravelli

doi: 10.1136/annrheumdis-2019-216310
Correspondence response
Response to: ‘The association between osteoporosis and statins therapy’ by Lai
Free

Michael Leutner, Caspar Matzhold, Luise Bellach, Carola Deischinger, Jürgen Harreiter, Stefan Thurner, Peter Klimek, Alexandra Kautzky-Willer

doi: 10.1136/annrheumdis-2019-216494

October 24, 2019

Vasculitis
Clinical symptoms and associated vascular imaging findings in Takayasu’s arteritis compared to giant cell arteritis

Despina Michailidou, Joel S Rosenblum, Casey A Rimland, Jamie Marko, Mark A Ahlman, Peter C Grayson

doi: 10.1136/annrheumdis-2019-216145

October 19, 2019

Rheumatoid arthritis
Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial

Yoshiya Tanaka, Koji Oba, Takao Koike, Nobuyuki Miyasaka, Tsuneyo Mimori, Tsutomu Takeuchi, Shintaro Hirata, Eiichi Tanaka, Hidekata Yasuoka, Yuko Kaneko, Kosaku Murakami, Tomohiro Koga, Kazuhisa Nakano, Koichi Amano, Kazuyasu Ushio, Tatsuya Atsumi, Masayuki Inoo, Kazuhiro Hatta, Shinichi Mizuki, Shouhei Nagaoka, Shinichiro Tsunoda, Hiroaki Dobashi, Nao Horie, Norihiro Sato

doi: 10.1136/annrheumdis-2019-216169

October 18, 2019

Correspondence
Role of ANA testing in the classification of patients with systemic lupus erythematosus
Free

David S Pisetsky, Diane M Spencer, Brad Rovin, Peter E Lipsky

doi: 10.1136/annrheumdis-2019-216259
Correspondence
Application of MS score in macrophage activation syndrome patients associated with adult onset Still’s disease
Free

Ran Wang, Ting Li, Shuang Ye, Wenefng Tan, Cheng Zhao, Yisha Li, Chunde Bao, Qiong Fu

doi: 10.1136/annrheumdis-2019-216286
Correspondence response
On how to not misuse hierarchical clustering on principal components to define clinically meaningful patient subgroups. Response to: ‘On using machine learning algorithms to define clinical meaningful patient subgroups’ by Pinal-Fernandez and Mammen
Free

Alain Meyer, Lionel Spielmann, François Séverac

doi: 10.1136/annrheumdis-2019-215868
Correspondence
Gut-derived CD8⁺ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients
Free

Giuliana Guggino, Aroldo Rizzo, Daniele Mauro, Federica Macaluso, Francesco Ciccia

doi: 10.1136/annrheumdis-2019-216456

October 15, 2019

Correspondence response
Response to: ‘Diabetes mellitus in ankylosing spondylitis’ by Lee and Song
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-216429
Correspondence response
Possible adaptations of vascularised human skin equivalents to include rare cell populations and study fibroblast heterogeneity. Response to: ‘In search for the ideal anatomical composition of vascularised human skin equivalents for systemic sclerosis translational research: should we recruit the telocytes?’ by Manetti and Matucci-Cerinic
Free

Alexandru Emil Matei, Jörg H W Distler

doi: 10.1136/annrheumdis-2019-216393
Correspondence response
Response to: ‘Comment on: standardisation of myositis-specific antibodies: where are we today?’ by Infantino et al
Free

Johan Rönnelid, Fabricio Espinosa-Ortega, Ingrid E Lundberg

doi: 10.1136/annrheumdis-2019-216248
Correspondence
Diabetes mellitus in ankylosing spondylitis
Free

Young Ho Lee, Gwan Gyu Song

doi: 10.1136/annrheumdis-2019-216335
Letter
Rapid induction of clinical remission by immunoadsorption for refractory lupus retinopathy complicated with life-threatening neuropsychiatric lupus

Guangfeng Zhang, Xiao Zhang, Yunfei Chai, Siwen Zang, Yunzhen Shi, Haijun Wu

doi: 10.1136/annrheumdis-2019-215930

October 14, 2019

Correspondence
Titre-specific positive predictive value of antinuclear antibody patterns
Free

Jean-Baptiste Vulsteke, Lieve Van Hoovels, Philippe Willems, Bert Vander Cruyssen, Steven Vanderschueren, Rene Westhovens, Daniel Blockmans, Ellen De Langhe, Xavier Bossuyt

doi: 10.1136/annrheumdis-2019-216245
Correspondence
Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2
Free

Sheng-Xiao Zhang, Jia Wang, He-Hua Sun, Jia-Qian Zhang, Guang-Ying Liu, Jing Luo, Pei-Feng He, Xiao-Feng Li

doi: 10.1136/annrheumdis-2019-216246
Correspondence
Incidence of inflammatory bowel disease in patients with ankylosing spondylitis
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-216362
Sjögren’s syndrome
Antigen-driven selection of antibodies against SSA, SSB and the centromere ‘complex’, including a novel antigen, MIS12 complex, in human salivary glands

Masaru Takeshita, Katsuya Suzuki, Yukari Kaneda, Humitsugu Yamane, Kazuhiro Ikeura, Hidekazu Sato, Shin Kato, Kazuyuki Tsunoda, Hisashi Arase, Tsutomu Takeuchi

doi: 10.1136/annrheumdis-2019-215862
Correspondence
Bone health in patients with systemic lupus erythematosus
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-216417
Correspondence response
On the therapeutic scope of low-dose IL-2. Response to: ‘Circulating regulatory T cells were absolutelydecreased in dermatomyositis/polymyositispatients and restored by low-dose IL-2’ by Zhang et al
Free

David Klatzmann

doi: 10.1136/annrheumdis-2019-216267

October 11, 2019

Correspondence response
Response to: ‘Response to: “Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients” by Fornaro et al’ by Agca et al
Free

Marco Fornaro, Fabio Cacciapaglia, Vincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone

doi: 10.1136/annrheumdis-2019-216407
Correspondence response
Importance of high-quality ANA testing for SLE classification. Response to: ‘Role of ANA testing in the classification of patients with systemic lupus erythematosus’ by Pisetsky et al
Free

Martin Aringer, Karen H Costenbader, Thomas Dörner, Sindhu R Johnson

doi: 10.1136/annrheumdis-2019-216337
Correspondence
Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients
Free

Mariko Ogawa-Momohara, Yoshinao Muro, Masashi Akiyama

doi: 10.1136/annrheumdis-2019-216375

October 10, 2019

Correspondence response
Response to ‘Titre-specific positive predictive value of anti-nuclear antibody patterns’ by Vulsteke et al
Free

Jan Damoiseaux, Luís Eduardo Coelho Andrade, Marvin J Fritzler, Manfred Herold, Maria Infantino, Carlos von Muhlen

doi: 10.1136/annrheumdis-2019-216266
Correspondence response
Response to: ‘Medications associated with fracture risk in patients with rheumatoid arthritis’ by Chen et al
Free

Gulsen Ozen, Kaleb Michaud

doi: 10.1136/annrheumdis-2019-216293
Correspondence
Association of anti-Ro52 autoantibodies with interstitial lung disease in connective tissue diseases
Free

Si Wu, Xiaojun Tang, Liping Wu, Liang-jing Lu, Xuebing Feng

doi: 10.1136/annrheumdis-2019-216372
Correspondence response
Could we use salivary gland ultrasonography as a prognostic marker in Sjogren’s syndrome? Response to: ‘Ultrasonographic damages of major salivary glands are associated with cryoglobulinemic vasculitis and lymphoma in primary Sjogren’s syndrome: are the ultrasonographic features of the salivary glands new prognostic markers in Sjogren's syndrome?’ by Coiffier et al
Free

Sandrine Jousse-Joulin, Maria Antonietta D'Agostino, Alojzija Hočevar, Esperanza Naredo, Lene Terslev, Sarah Ohrndorf, Annamaria Iagnocco, Wolfgang A Schmidt, Stephanie Finzel, Zarrin Alavi, George A W Bruyn on behalf the Salivary Gland subgroup of the OMERACT US working group

doi: 10.1136/annrheumdis-2019-216327

October 04, 2019

Letter
Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?

Johan Karlsson Wallman, Elisabeth Mogard, Jan Marsal, Kristofer Andréasson, Anna Jöud, Mats Geijer, Lars Erik Kristensen, Elisabet Lindqvist, Tor Olofsson

doi: 10.1136/annrheumdis-2019-216134
Correspondence response
Difference between SLE classification and diagnosis and importance of attribution. Response to: ‘Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?’ by Chi et al
Free

Martin Aringer, Karen H Costenbader, Thomas Dörner, Sindhu R Johnson

doi: 10.1136/annrheumdis-2019-216338

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

November 14, 2019

November 11, 2019

November 09, 2019

November 08, 2019

November 07, 2019

November 06, 2019

November 05, 2019

November 04, 2019

October 31, 2019

October 30, 2019

October 29, 2019

October 25, 2019

October 24, 2019

October 19, 2019

October 18, 2019

October 15, 2019

October 14, 2019

October 11, 2019

October 10, 2019

October 04, 2019

Pages